Compare Campbell Soup Co. (CPB) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Campbell Soup Co. vs 10X Genomics Inc — how do they compare? Campbell Soup Co. trades at $19.2 (market cap $5.78B), while 10X Genomics Inc trades at $80.87 (market cap $10.07B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and Campbell Soup Co. pays a 5.16% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Campbell Soup Co. for 98 Days and 10X Genomics Inc for 91 Days on average.
| CPB | TXG | |
|---|---|---|
Market Cap | $5.78B | $10.07B |
Volume | 11,705,427 | 5,657,286 |
Sector | Consumer Staples | Health |
52-Week High | $31.66 | $97.74 |
52-Week Low | $18.90 | $11.48 |
Typical Hold Time | 98 Days | 91 Days |
Enterprise Value | $12.83B | $9.59B |
Dividend Yield | 5.16% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Campbell's stock trades at $19.21, up 1.64% today, as the company navigates a challenging period marked by a recent 36% dividend cut and Q4 earnings miss. Technical indicators show bearish momentum with the stock trading near key support at $19, while fundamentals reveal mixed performance with revenue growth to $10.25B but declining net margins to 4.14%. The company has initiated a $500 million cost savings program and workforce reduction to address profitability concerns.
The outlook remains cautious with analyst consensus leaning heavily toward Hold (58.62%) amid execution risks of the turnaround plan. While the current P/E of 14.79 offers reasonable valuation, investors face headwinds from margin compression and competitive pressures in the packaged foods sector. The stock presents a value opportunity for patient investors but requires careful monitoring of cost-saving initiatives and sales stabilization.
10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.
The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
